Drug allergy delabeling in the clinical setting
Drug allergy delabeling refers to the removal of a listed drug from the allergy section. In an ideal scenario, the removal of the patient allergy label is then communicated in a streamlined process to the patient and their health care settings. The future of large-scale drug allergy delabeling rests on multiple factors: culture shifts, easily adapted tools to delabel our largest drug allergy categories, and electronic health record (EHR) crosstalk. The present functionalities of most EHR allergy sections and ignorance of their content are at odds with our universal goals of providing highly reliable, expert, safe, and affordable care.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Margee Louisias, Paige Wickner Tags: Perspective Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Electronic Health Records (EHR) | Health Management